U.S. attaches importance to pharmaceutics development in ArmeniaNovember 16, 2010 - 14:12 AMT PanARMENIAN.Net - Armenia can be a good pharmaceutical country, as it has experienced chemists, technological base and favorable investment climate, according to USAID/Armenia Deputy Mission Director John Seong. “The U.S. attaches importance to development of pharmaceutics in Armenia. Local manufacture of medicine helps diversify the economy, create job opportunities and make high-quality medicine affordable for the population,” Mr. Seong said, adding that the legislation should be reformed and investments attracted to develop pharmaceutics in the country. Top stories Yerevan has dismissed Turkey’s demand to shut down the Armenian nuclear power plant as “inappropriate”. Armenia will loan 2.9 billion drams to Nagorno Karabakh (Artsakh), according to a draft government decision. The Ministry of Ecology and Natural Resources of Azerbaijan has “strongly condemned” Armenia’s decision. Kerobyan has said that for the first time in the history of Armenia, the volume of foreign direct investments amounted to about $1 billion. Partner news | Mirzoyan says meeting with Bayramov was “constructive” At the moment, Ararat Mirzoyan said, there is no basis for additional comments. OSCE vows support for Armenia “in all three directions of security” Achieving stable peace between Armenia and Azerbaijan remains a priority of the OSCE, said Ian Borg. 151 detained as civil disobedience campaigns continue in Yerevan Citizens have been blocking streets in the Armenian capital, demanding Nikol Pashinyan’s resignation. France welcomes Armenia-Azerbaijan meeting in Almaty France has welcomed the new round of negotiations between the foreign ministers of Armenia and Azerbaijan. |